Ion Channels and Cancer
Ion channels are critical signaling proteins in all of the main hallmarks of cancer – see image above. Indeed, Prof. Saverio Gentile of the University of Illinois, Chicago, has pithily defined this inextricable connection as ‘a channelopathy called cancer’.
Sophion are at the forefront of ion channel research supporting and collaborating with world-leading oncochannelopathy labs, including hosting presentations on their findings at our Ion Channel Modulation Symposia, User Meetings & webinars.
Links to recordings of these lectures are given below.
Prof. Annarosa Archangeli, ICMS 2017, ‘hERG Channels: From anti-targets to novel targets for cancer therapy’
Dr Luis Pardo, ICMS 2017, ‘Kv10.1 and the cell cycle: A two-way road’
Prof. Mustafa Djamgoz, ICMS 2019, ‘In vivo evidence for expression of voltage-gated sodium channels in cancer and potentiation of metastasis’
Prof. Saverio Gentile, User Meeting 2021, ‘Targeting potassium channels in cancer from cell signaling to precision medicine